Patients' preferences in choosing therapy for retinal vein occlusions

被引:13
作者
Chang, Margaret A.
Fine, Howard F.
Bass, Eric
Bressler, Susan B.
Schachat, Andrew P.
Solomon, Sharon D.
Bressler, Neil M.
机构
[1] Retina Div, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Internal Med, Baltimore, MD USA
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2007年 / 27卷 / 06期
关键词
preference values; quality-of-life measurements; retinal vein occlusion;
D O I
10.1097/IAE.0b013e31802c0a34
中图分类号
R77 [眼科学];
学科分类号
100212 [眼科学];
摘要
Purpose: The purpose of this study was to assess preference values for vein occlusions with macular edema and to determine how this may affect patient perceptions of potential treatments. Methods: The Submacular Surgery Trials Vision Preference Value Scale and questions regarding enthusiasm for potential treatments were administered to 153 patients with vein occlusion. Univariate analyses identified predictors of preference values, followed by adjustment for potential confounders using multivariate linear regression. Relationships between preference values and enthusiasm for potential treatments were assessed. Results: The mean preference values +/- SD were similar for patients with branch vein occlusions and central vein occlusions (0.65 +/- 0.20). Lower preference values were associated with duration of occlusion of >2 years (P = 0.03) and poorer last-recorded visual acuity (P = 0.02). Approximately one half of patients were moderately or very enthusiastic about undergoing intravitreal injection. Sixty-nine percent of branch vein occlusion patients were moderately or very enthusiastic about the standard of care, laser photocoagulation; only one third of central vein occlusion patients were moderately or very enthusiastic about standard observation. Conclusions: These data suggest that vein occlusion with macular edema has a significant impact on quality of life. Most patients were willing to undergo potentially invasive treatment.
引用
收藏
页码:789 / 797
页数:9
相关论文
共 53 条
[1]
[Anonymous], 1987, ARCH OPHTHALMOL-CHIC, V105, P1499
[2]
[Anonymous], 1984, AM J OPHTHALMOL, V98, P271
[3]
Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion [J].
Bashshur, ZF ;
Ma'luf, RN ;
Allam, S ;
Jurdi, FA ;
Haddad, RS ;
Noureddin, BN .
ARCHIVES OF OPHTHALMOLOGY, 2004, 122 (08) :1137-1140
[4]
Bass EB, 2004, ARCH OPHTHALMOL-CHIC, V122, P1856
[5]
Preference values for visual states in patients planning to undergo cataract surgery [J].
Bass, EB ;
Wills, S ;
Scott, IU ;
Javitt, JC ;
Tielsch, JM ;
Schein, OD ;
Steinberg, EP .
MEDICAL DECISION MAKING, 1997, 17 (03) :324-330
[6]
Brown G C, 2001, Trans Am Ophthalmol Soc, V99, P199
[7]
Brown GC, 2000, ARCH OPHTHALMOL-CHIC, V118, P47
[8]
Incremental cost-effectiveness of laser therapy for visual loss secondary to branch retinal vein occlusion [J].
Brown, GC ;
Brown, MM ;
Sharma, S ;
Busbee, B ;
Brown, H .
OPHTHALMIC EPIDEMIOLOGY, 2002, 9 (01) :1-10
[9]
A utility analysis correlation with visual acuity: Methodologies and vision in the better and poorer eyes [J].
Brown M.M. ;
Brown G.C. ;
Sharma S. ;
Smith A.F. ;
Landy J. .
International Ophthalmology, 2001, 24 (3) :123-127
[10]
Quality of life associated with visual loss - A time tradeoff utility analysis comparison with medical health states [J].
Brown, MM ;
Brown, GC ;
Sharma, S ;
Busbee, B .
OPHTHALMOLOGY, 2003, 110 (06) :1076-1081